Full-text

Journal article

The role of biosimilar manufacturers in improving access to insulin globally.

Perrin C Independent consultant, Paris, France.
Ewen M Health Action International, Amsterdam, Netherlands.
Beran D University of Geneva and Geneva University Hospitals, 1211 Geneva, Switzerland. Electronic address: david.beran@unige.ch.

2017-06-21

Published in:

The lancet. Diabetes & endocrinology. - 2017

Biosimilar Pharmaceuticals

Drug Industry

Global Health

Health Services Accessibility

Humans

Hypoglycemic Agents

Insulin

Language

English

Open access status

bronze

Identifiers

DOI 10.1016/S2213-8587(17)30218-8
PMID 28629907

Persistent URL

https://sonar.ch/global/documents/232799

Statistics

Document views: 23 File downloads:

Full-text: 0